Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2008

Aug 28, 2008

30339_dirs_2008-08-28_74bfd2f9-7100-4bbe-bef2-9777dad9fe89.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2008-08-27

Reporting Person: ABBOTT JOSEPH E (Corporate Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2008-08-27 Common Stock M 6000 $14.41 Acquired 21635.2346 Direct
2008-08-27 Common Stock S 6000 $49.0295 Disposed 15635.2346 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2008-08-27 Stock Option (Right to Buy) $14.41 M 6000 Disposed 2012-03-09 Common Stock (6000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2903.7703 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.